Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF) in 2011, we investigated clinical management practices for patients with IPF according to physicians' diagnoses. A prospective, multicenter, noninterventional study with comprehensive quality measures including on-site source data verification was performed in Germany. 502 consecutive patients (171 newly diagnosed, 331 prevalent; mean± sd age 68.7±9.4 years, 77.9% males) with a mean disease duration of 2.3±3.5 years were enrolled. IPF diagnosis was based on clinical assessments and high-resolution computed tomography (HRCT) in 90.2%, and on surgical lung biopsy combined with histology in 34.1% (lavage in 61.8%). The median 6-min walk distance was 320 m (mean 268±200 m). The mean forced vital capacity was 72±20% pred and diffusing capacity of the lung for carbon monoxide was 35±15% pred. No drugs were administered in 17.9%, oral steroids in 23.7%, N -acetylcysteine in 33.7%, pirfenidone in 44.2% and other drugs in 4.6% of patients. Only 2.8% of the cohort was listed for lung transplantation. IPF patients were diagnosed in line with the new guidelines. They had more severe disease than those enrolled in recent randomised controlled trials. In addition to HRCT, the frequency of lung biopsies was surprisingly high. Treatment patterns varied substantially.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationQuanjer, P. H., Stanojevic, S., Cole, T. J., Baur, X., Hall, G. L., Culver, B. H., Enright, P. L., Hankinson, J. L., Ip, M. S. M., Zheng, J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00080312 · Cited by 5,919
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
(1993) · PubMed · Cited by 3,827
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Reference spirometric values using techniques and equipment that meet ATS recommendations.
Terrin, M. (1981) · PubMed · doi:10.1164/arrd.1981.124.6.763c · Cited by 1,374
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Ley, B., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Tomassetti, S., Lee, J. S., Poletti, V., Buccioli, M., Elicker, B. M., Jones, K. D., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00004 · Cited by 1,308
Delgado-Rodríguez, M., & Llorca, J. (2004) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2003.008466 · Cited by 1,064
Editorial: Cerebral Palsy—the International Consensus Statement
Clements, R. V., & Simanowitz, A. (2000) · Clinical Risk · doi:10.1177/135626220000600401 · Cited by 856
international consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Reference spirometric values using techniques and equipment that meet ATS recommendations.
Crapo, R. O., Morris, A. H., & Gardner, R. M. (1981) · PubMed · doi:10.1164/arrd.1981.123.6.659 · Cited by 614
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
Turner-Warwick, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.3.171 · Cited by 508
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401739 · Cited by 505
Ries, A. L. (2005) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200050655 · Cited by 405
The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF
Swigris, J. J., Brown, K. K., Behr, J., du Bois, R. M., King, T. E., Raghu, G., & Wamboldt, F. S. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.09.006 · Cited by 247
Self-citationFuture Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1141ws · Cited by 236
Is nedocromil sodium effective treatment for asthma?
O'Byrne, P., & Cook, D. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06010005 · Cited by 223
Significance of Bronchoalveolar Lavage for the Diagnosis of Idiopathic Pulmonary Fibrosis
Ohshimo, S., Bonella, F., Cui, A., Beume, M., Kohno, N., Guzman, J., & Costabel, U. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1313oc · Cited by 220
Johnston, I. D., Prescott, R. J., Chalmers, J. C., & Rudd, R. M. (1997) · Thorax · doi:10.1136/thx.52.1.38 · Cited by 205
Influence of secular trends and sample size on reference equations for lung function tests
Quanjer, P. H., Stocks, J., Cole, T. J., Hall, G. L., & Stanojevic, S. (2011) · European Respiratory Journal · doi:10.1183/09031936.00110010 · Cited by 180
Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis?
Cottin, V., & Cordier, J.-F. (2012) · European Respiratory Journal · doi:10.1183/09031936.00001612 · Cited by 178
The role of cardiac registries in evidence-based medicine
Gitt, A. K., Bueno, H., Danchin, N., Fox, K., Hochadel, M., Kearney, P., Maggioni, A. P., Opolski, G., Seabra-Gomes, R., & Weidinger, F. F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp596 · Cited by 154
Ringbaek, T., Martinez, G., & Lange, P. (2012) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.630248 · Cited by 153
Patient experiences with pulmonary fibrosis
Collard, H. R., Tino, G., Noble, P. W., Shreve, M. A., Michaels, M., Carlson, B. W., & Schwarz, M. I. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.10.002 · Cited by 133
Raghu, G. (2011) · European Respiratory Journal · doi:10.1183/09031936.00017711 · Cited by 114
S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose
Behr, J., Günther, A., Ammenwerth, W., Bittmann, I., Bonnet, R. B., Buhl, R., Eickelberg, O., Ewert, R., Gläser, S., Gottlieb, J., et al. (2013) · Pneumologie · doi:10.1055/s-0032-1326009 · Cited by 110
Self-citationMinimal Clinically Important Difference for the UCSD Shortness of Breath Questionnaire
Kupferberg, D. H., Kaplan, R. M., Slymen, D. J., & Ries, A. L. (2005) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200511000-00011 · Cited by 109
Are data from clinical registries of any value?
Alpert, J. S. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2265 · Cited by 100
Guidelines for good pharmacoepidemiology practices (GPP)
Epstein, M. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1082 · Cited by 90
Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis
Peikert, T., Daniels, C. E., Beebe, T. J., Meyer, K. C., & Ryu, J. H. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.03.018 · Cited by 77
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
Antoniou, K. M., Margaritopoulos, G. A., & Siafakas, N. M. (2013) · European Respiratory Review · doi:10.1183/09059180.00002113 · Cited by 53
Triple therapy in idiopathic pulmonary fibrosis: an alarming press release
Wells, A. U., Behr, J., Costabel, U., Cottin, V., & Poletti, V. E. (2012) · European Respiratory Journal · doi:10.1183/09031936.00009112 · Cited by 44
Self-citationManagement of idiopathic pulmonary fibrosis in France: A survey of 1244 pulmonologists
Cottin, V., Cadranel, J. L., Crestani, B., Dalphin, J., Delaval, P., Israël‐Biet, D., Kessler, R., Reynaud‐Gaubert, M., Valeyre, D., Wallaert, B., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.11.017 · Cited by 31
Behr, J., Hoeper, M. M., Kreuter, M., Klotsche, J., Wirtz, H., & Pittrow, D. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2013-000010 · Cited by 28
Self-citationWilson, J. W., du Bois, R. M., & King, T. E. (2008) · Thorax · doi:10.1136/thx.2004.031062 · Cited by 27
A global registry for idiopathic pulmonary fibrosis: the time is now
Ryerson, C. J., Corte, T. J., Collard, H. R., & Richeldi, L. (2014) · European Respiratory Journal · doi:10.1183/09031936.00051914 · Cited by 27
Charakteristika und Versorgung der idiopathischen Lungenfibrose
Behr, J., Hoeper, M., Kreuter, M., Klotsche, J., Wirtz, H., & Pittrow, D. (2012) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0032-1327244 · Cited by 11
Self-citationBehr, J., Günther, A., Ammenwerth, W., Bittmann, I., Buhl, R., Eickelberg, O., Ewert, R., Gläser, S., Gottlieb, J., Kreuter, M., et al. (2013) · Cited by 6
Self-citation
Cited by
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
“More men have been reported with IPF than women, and the majority of patients have a history of past cigarette smoking (13).”
BackgroundSelf-citationWijsenbeek, M., Suzuki, A., & Maher, T. M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01052-2 · Cited by 539
Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management
Vasakova, M., Morell, F., Walsh, S., Leslie, K., & Raghu, G. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2201pp · Cited by 456
“Lymphocyte count also reflects the different histopathologic patterns seen in HP, with the highest counts present in organizing pneumonia and cellular nonspecific cellular interstitial pneumonia, and the lowest, but still increased, counts in a UIP-like pattern (51, 52).”
BackgroundImpact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
Kreuter, M., Ehlers-Tenenbaum, S., Palmowski, K., Bruhwyler, J., Oltmanns, U., Muley, T., Heussel, C. P., Warth, A., Kolb, M., & Herth, F. J. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151425 · Cited by 351
“000 (reviewed in [2]), mainly diagnosed in the elderly where the prevalence increases dramatically and a predominance in men and ex/current smokers [1, 3].”
BackgroundSelf-citationOldham, J. M., Ma, S.-F., Martinez, F. J., Anstrom, K. J., Raghu, G., Schwartz, D. A., Valenzi, E., Witt, L., Lee, C., Vij, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1010oc · Cited by 341
Metadata
- Authors
- Behr, J., Kreuter, M., Hoeper, M. M., Wirtz, H., Klotsche, J., Koschel, D., Andreas, S., Claussen, M., Grohé, C., Wilkens, H., Randerath, W., Skowasch, D., Meyer, F. J., Kirschner, J., Gläser, S., Herth, F. J. F., Welte, T., Huber, R. M., Neurohr, C., Schwaiblmair, M., Kohlhäufl, M., Höffken, G., Held, M., Koch, A., Bahmer, T., & Pittrow, D.
- Corresponding author
- Behr, Jürgen
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2015-04-02
- Volume
- 46
- Issue
- 1
- Pages
- 186-196
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC4486374
- OpenAlex
- W2051083934
- Cited by
- 247
- References
- 41
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 10 · 2023: 18 · 2022: 28 · 2021: 26 · 2020: 38 · 2019: 27 · 2018: 26 · 2017: 25 · 2016: 20 · 2015: 11
- FWCI
- 21.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- GRO (submittedVersion)
- Funders
- Boehringer Ingelheim
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, clinical management practices, treatment patterns, pirfenidone, N-acetylcysteine, corticosteroids, lung transplantation, open lung biopsy, high-resolution computed tomography, guideline adherence
- MeSH terms
- Acetylcysteine, Aged, Anti-Inflammatory Agents, Non-Steroidal, Biopsy, Exercise Test, Female, Germany, Humans, Lung, Male, Middle Aged, Prospective Studies, Pyridones, Registries, Steroids, Tomography, X-Ray Computed, Vital Capacity, Practice Guidelines as Topic, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.